UK’s MRC invests in research into hard-to-treat cancers
UK Research and Innovation’s (UKRI) Medical Research Council (MRC) is investing £2 million to support research into cancers with poor [...]
Government funds to grow UK life sciences workforce and upgrade science facility
As part of its £650m ‘Life Sci for Growth’ scheme to boost the life sciences sector and the wider economy, [...]
UK rejoins Horizon Europe
Britain’s life science community is celebrating the country’s return to the EU Horizon Europe research programme, which was announced on [...]
Public and HCP trust in UK pharma industry maintained
The third annual Pharma Reputation Index, commissioned by the Association of the British Pharmaceutical Industry (ABPI), has found that the [...]
MHRA consults on ending EC Decision Reliance Procedure
The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting feedback on plans to end use of the European Commission [...]
Still no UK-EU agreement on Horizon Europe
Roadblocks from the EU, and the UK government’s determination to get a ‘fair settlement’ on associate membership, are harming international [...]
Clarification on continuation of CE marking in UK
The UK’s Department for Business and Trade (DBT) has announced an indefinite extension to the use of CE marking for [...]
Calling biotech startups
Whether you are heading off to the beach this summer or relaxing at home, this quieter period is a good [...]
MHRA publishes annual report for 2022-2023
The UK Medicines and Healthcare products Regulatory Agency’s (MHRA) annual report and accounts for 2022-2023 was printed on 19 July [...]
UK government consults on draft legislation on merged R&D tax relief
Draft legislation has been published by the UK government on a proposed merged R&D tax relief scheme. If implemented, the [...]
Why we need Medical Affairs 3.0
New biotechs and small pharma companies find it hard to take their products from discovery to market because of a [...]
Pharma organisations tussle over VPAS negotiations
A High Court judgment on a judicial review brought by the British Generic Manufacturers Association (BGMA) has dismissed the organisation’s [...]
International investment in UK life sciences plummets
Figures from the ninth annual life sciences competitiveness indicators (LSCIs) report show that in 2022 the UK saw a substantial [...]
MHRA announces corporate plan for 2023-2026
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published its corporate plan for the next three years, featuring [...]
NIHR and MRC launch UK Rare Disease Research Platform
The National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC) are investing £14 million in [...]